- Home
- INLX vs XCUR Comparison
INLX vs XCUR Comparison
Compare INLX & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INLX
- XCUR
- Stock Information
- Founded
- INLX 1996
- XCUR 2011
- Country
- INLX United States
- XCUR United States
- Employees
- INLX N/A
- XCUR N/A
- Industry
- INLX EDP Services
- XCUR Biotechnology: Pharmaceutical Preparations
- Sector
- INLX Technology
- XCUR Health Care
- Exchange
- INLX Nasdaq
- XCUR Nasdaq
- Market Cap
- INLX 60.5M
- XCUR 74.1M
- IPO Year
- INLX N/A
- XCUR N/A
- Fundamental
- Price
- INLX $14.47
- XCUR $11.38
- Analyst Decision
- INLX
- XCUR
- Analyst Count
- INLX 0
- XCUR 0
- Target Price
- INLX N/A
- XCUR N/A
- AVG Volume (30 Days)
- INLX 3.5K
- XCUR 31.6K
- Earning Date
- INLX 05-16-2025
- XCUR 06-16-2025
- Dividend Yield
- INLX N/A
- XCUR N/A
- EPS Growth
- INLX N/A
- XCUR N/A
- EPS
- INLX N/A
- XCUR N/A
- Revenue
- INLX $18,018,373.00
- XCUR $500,000.00
- Revenue This Year
- INLX $7.58
- XCUR N/A
- Revenue Next Year
- INLX N/A
- XCUR N/A
- P/E Ratio
- INLX N/A
- XCUR N/A
- Revenue Growth
- INLX 6.70
- XCUR N/A
- 52 Week Low
- INLX $5.85
- XCUR $1.44
- 52 Week High
- INLX $16.50
- XCUR $36.00
- Technical
- Relative Strength Index (RSI)
- INLX 55.56
- XCUR 51.56
- Support Level
- INLX $12.00
- XCUR $9.81
- Resistance Level
- INLX $14.99
- XCUR $11.58
- Average True Range (ATR)
- INLX 0.67
- XCUR 1.00
- MACD
- INLX -0.09
- XCUR 0.02
- Stochastic Oscillator
- INLX 66.40
- XCUR 58.32
About INLX Intellinetics Inc.
Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.